Expert opinion
Watch Dr Joslyn Kirby discussing the latest insights in hidradenitis suppurativa (HS) surrounding:
- The impact, progression and pathophysiology of HS
- Unmet needs in HS diagnosis and treatment
- Treatment options and the evolving treatment landscape
Dr Kirby discusses the importance of raising awareness of HS across multiple specialties to improve diagnosis and allow patients to get the right treatment.
Pathophysiology and risk factors
“All of the immune system seems to be active in HS.” Dr Joslyn Kirby outlines current understanding of the causes of HS.
Dr Joslyn Kirby considers the roles of genetics and environmental and behavioural factors in HS risk.
Dr Joslyn Kirby highlights the variability of HS severity and likelihood of progression, and the impact this has on treatment decisions.
Burden of disease for people with HS
Dr Joslyn Kirby outlines the severe psychological and physical impact of HS symptoms on quality of life.
Dr Joslyn Kirby explains why HS is frequently underdiagnosed and the importance of individualising treatment based on the activity and severity of HS lesions.
Treatment of HS
Dr Joslyn Kirby outlines the treatment goals of HS from short-term management of flares to long-term control of the disease.
Dr Joslyn Kirby describes the established treatment approach for HS, highlighting the need to balance safety against the impact of the disease.
Dr Joslyn Kirby explains how a better understanding of HS pathophysiology is driving the development of novel treatments that could improve outcomes for people with HS.
Dr Joslyn Kirby describes how recent research is paving the way towards individualised treatment for people with HS.
This video provides more information about Dr Joslyn Kirby from Penn State University, Pennsylvania, USA.
of interest
are looking at
saved
next event
Developed by EPG Health for Medthority. This content has been developed independently of the sponsor Novartis Pharma AG, who have had no editorial input into the content. EPG Health received unrestricted educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.